Literature DB >> 19435861

No association between matrix metalloproteinase (MMP)-1, MMP-3, and MMP-7 SNPs and endometrial cancer risk.

Alicia Beeghly-Fadiel1, Yong-Bing Xiang, Sandra L Deming, Ji-Rong Long, Wang-Hong Xu, Qiuyin Cai, Wei Zheng, Xiao Ou Shu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19435861      PMCID： PMC2770800          DOI： 10.1158/1055-9965.EPI-09-0244

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN： 1055-9965            Impact factor:   4.254


× No keyword cloud information.
  35 in total

1.  The International HapMap Project.

Authors: 
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

2.  Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression.

Authors:  S Ye; P Eriksson; A Hamsten; M Kurkinen; S E Humphries; A M Henney
Journal:  J Biol Chem       Date:  1996-05-31       Impact factor: 5.157

3.  Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients.

Authors:  S Jormsjö; C Whatling; D H Walter; A M Zeiher; A Hamsten; P Eriksson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-11       Impact factor: 8.311

4.  Association of matrix metalloproteinase (MMP)-1 promoter polymorphism with head and neck squamous cell carcinoma.

Authors:  Tomoko Hashimoto; Kenichiro Uchida; Naoko Okayama; Yuji Imate; Yutaka Suehiro; Yuichiro Hamanaka; Yoshiya Ueyama; Fumihiko Shinozaki; Hiroshi Yamashita; Yuji Hinoda
Journal:  Cancer Lett       Date:  2004-07-28       Impact factor: 8.679

5.  Single nucleotide polymorphisms in MMP1 and MMP3 gene promoters as risk factor in head and neck squamous cell carcinoma.

Authors:  Franck Zinzindohoué; Hélène Blons; Stéphane Hans; Marie-Anne Loriot; Anne-Marie Houllier; Daniel Brasnu; Ollivier Laccourreye; David-Alexandre Tregouet; Isabelle Stucker; Pierre Laurent-Puig
Journal:  Anticancer Res       Date:  2004 May-Jun       Impact factor: 2.480

6.  A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription.

Authors:  J L Rutter; T I Mitchell; G Butticè; J Meyers; J F Gusella; L J Ozelius; C E Brinckerhoff
Journal:  Cancer Res       Date:  1998-12-01       Impact factor: 12.701

7.  Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis.

Authors:  S Ye; G F Watts; S Mandalia; S E Humphries; A M Henney
Journal:  Br Heart J       Date:  1995-03

8.  No association between matrix metalloproteinase-1 or matrix metalloproteinase-3 polymorphisms and breast cancer susceptibility: a report from the Shanghai Breast Cancer Study.

Authors:  Alicia Beeghly-Fadiel; Qiuyin Cai; Wei Lu; Jirong Long; Yu-Tang Gao; Xiao-Ou Shu; Wei Zheng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-24       Impact factor: 4.254

Review 9.  The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle.

Authors:  Thomas E Curry; Kevin G Osteen
Journal:  Endocr Rev       Date:  2003-08       Impact factor: 19.871

10.  A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter in endometrial carcinomas.

Authors:  Y Nishioka; K Kobayashi; S Sagae; S Ishioka; A Nishikawa; M Matsushima; Y Kanamori; T Minaguchi; Y Nakamura; T Tokino; R Kudo
Journal:  Jpn J Cancer Res       Date:  2000-06
View more
  3 in total

1.  Association of Matrix Metalloproteinase-1 Genotypes With Bladder Cancer Risk.

Authors:  Cheng-Hsi Liao; Chia-Wen Tsai; Wen-Shin Chang; Zhi-Hong Wang; Chi-Li Gong; Hsi-Chin Wu; Bo-Ren Wang; Shih-Wei Hsu; Wen-Chin Huang; Te-Chun Shen; DA-Tian Bau
Journal:  In Vivo       Date:  2021 Sep-Oct       Impact factor: 2.155

2.  Plasma levels of MMP-7 and TIMP-1 in laboratory diagnostics and differentiation of selected histological types of epithelial ovarian cancers.

Authors:  Grażyna Ewa Będkowska; Ewa Gacuta; Monika Zajkowska; Edyta Katarzyna Głażewska; Joanna Osada; Maciej Szmitkowski; Lech Chrostek; Milena Dąbrowska; Sławomir Ławicki
Journal:  J Ovarian Res       Date:  2017-06-29       Impact factor: 4.234

3.  Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer.

Authors:  Chiranjeevi Padala; Mohini Aiyengar Tupurani; Kaushik Puranam; Srilatha Gantala; Nivas Shyamala; Mrudula Spurthi Kondapalli; Kishore Kumar Gundapaneni; Saraswati Mudigonda; Rajesh Kumar Galimudi; Keerthi Kupsal; Santoshi Rani Nanchari; Uday Chavan; Sanjeeva Kumari Chinta; Srinivasulu Mukta; Vishnupriya Satti; Surekha Rani Hanumanth
Journal:  PLoS One       Date:  2017-09-29       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.